申请人:Pfizer Inc.
公开号:US04029731A1
公开(公告)日:1977-06-14
A series of novel 4-phenyl-1,2,3,4-tetrahydro-1-naphthylamines, including their pharmaceutically acceptable acid addition salts and their cis- and trans-isomers, have been prepared. The trans-isomers are useful in the field of mental health as antidepressant agents and/or as psychomotor stimulants. The trans-isomer of N-methyl-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine represents a preferred embodiment.
一系列新型的4-苯基-1,2,3,4-四氢-1-萘胺,包括其药学上可接受的酸盐和其顺反异构体已经被制备出来。其中,反异构体在心理健康领域中作为抗抑郁剂和/或精神运动刺激剂是有用的。N-甲基-4-苯基-1,2,3,4-四氢-1-萘胺的反异构体代表了一种首选实施方案。